Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
US Stock MarketDetailed Quotes
Barinthus Biotherapeutics (BRNS)
- 0.7110
- +0.0309+4.54%
Close May 14 16:00 ET
- 0.7110
- 0.00000.00%
Post 16:10 ET
29.04MMarket Cap-0.55P/E (TTM)
0.7246High0.6540Low34.51KVolume0.7200Open0.6801Prev Close24.06KTurnover0.13%Turnover RatioLossP/E (Static)40.85MShares2.920052wk High0.44P/B19.38MFloat Cap0.512052wk Low--Dividend TTM27.26MShs Float17.9900Historical High--Div Yield TTM10.38%Range %0.5120Historical Low0.6972Avg Price1Lot Size
Barinthus Biotherapeutics (BRNS) Key Financial Indicators
BRNS Earnings per Share (EPS)
According to the latest financial report of Barinthus Biotherapeutics, the latest earnings per share (TTM) for the company is -0.14. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
BRNS Free Cash Flow (FCF)
Interested in knowing about Barinthus Biotherapeutics's free cash flow? The latest report shows it as -3.37M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
BRNS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Barinthus Biotherapeutics shows that the company's current ratio is 6.05, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
BRNS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Barinthus Biotherapeutics, the quick ratio is 5.60, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
BRNS Return on Equity (ROE)
Want to learn more about the financial health of Barinthus Biotherapeutics? The latest ROE figure is -7.87%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
BRNS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Barinthus Biotherapeutics, the total asset return on investment (ROA) is -5.81%.
Currency: USD
Quarterly
Loading...
BRNS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Barinthus Biotherapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
BRNS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Barinthus Biotherapeutics, the net profit margin is -54.31%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm